Xerosis of the Vaginal Mucosa

Overview

Xerosis of the vaginal mucosa, commonly called vaginal dryness, is a condition in which the lining of the vagina becomes thin, less lubricated, and less elastic. The word “xerosis” comes from the Greek xeros meaning “dry.” This dryness can lead to discomfort, irritation, and pain during sexual activity or everyday activities such as walking or using the bathroom.

While xerosis is most frequently associated with the natural hormonal changes of menopause, it can affect women of any age. Estimates suggest that up to 50–60 % of post‑menopausal women experience some degree of vaginal dryness, and that number rises to 30 % in women under 40 who have certain medical or lifestyle risk factors.^[1][2]

Because the vaginal epithelium is part of the genitourinary system, xerosis can also be a sign of broader mucosal or systemic conditions, making accurate assessment essential.

Symptoms

The presentation of vaginal xerosis varies, but common symptoms include:

• Dryness or “tightness” – a noticeable lack of natural lubrication.
• Itching or burning – often described as a mild to moderate irritation that worsens after intercourse or with soap use.
• Vaginal pain (dyspareunia) – pain during or after sexual activity, sometimes accompanied by a “raw” feeling.
• Bleeding or spotting – especially after intercourse, due to fragile, thin mucosa.
• Increased urinary frequency or urgency – the urethra and vagina share similar mucosal tissue, so dryness can affect bladder symptoms.
• Feeling of “vaginal narrowing” – a sensation that the opening is smaller or less elastic.
• Discomfort during tampon or pessary use – irritation that makes these devices harder to tolerate.
• Reduced sexual desire – secondary to discomfort, leading to decreased libido.

Symptoms are often chronic, fluctuating with hormonal cycles, medication changes, or environmental factors.

Causes and Risk Factors

Hormonal Changes

• Menopause – Decline in estrogen reduces blood flow and glycogen content in the vaginal epithelium, leading to atrophy and dryness.^[3]
• Perimenopause – Hormonal fluctuations can cause intermittent dryness.
• Pregnancy & lactation – Elevated prolactin and hormonal shifts can temporarily reduce estrogen levels.

Medical Treatments & Medications

• Systemic estrogen antagonists (e.g., aromatase inhibitors for breast cancer) ^[4]
• Anti‑androgen therapies (e.g., spironolactone)
• Chemotherapy and radiation therapy involving the pelvic region
• Antihistamines, antidepressants (SSRIs), and some antihypertensives that have anticholinergic effects

Autoimmune & Dermatologic Conditions

• Lichen sclerosus and lichen planus – cause chronic inflammation and thinning of the mucosa.
• Sjögren’s syndrome – systemic dryness affecting vaginal tissue.

Lifestyle & Environmental Factors

• Smoking – vasoconstriction reduces blood supply to the genital area.
• High‑stress levels – can alter cortisol and indirectly affect estrogen metabolism.
• Frequent use of douches, scented soaps, or harsh detergents – disrupt the natural vaginal flora and mucosal integrity.

Other Risk Factors

• Early menopause (before age 45)
• History of pelvic surgery or radiation
• Low body mass index (BMI) – less peripheral conversion of androgens to estrogen.

Diagnosis

Diagnosing vaginal xerosis involves a combination of patient history, physical examination, and selective testing.

Clinical History

• Onset, duration, and pattern of symptoms.
• Menstrual and reproductive history, including menopause status.
• Medication review (including over‑the‑counter products).
• Sexual activity and any associated pain.
• Personal or family history of autoimmune or dermatologic disease.

Physical Examination

• Speculum examination – visual assessment of mucosal color (pale or erythematous), texture (thin, friable), and presence of fissures.
• pH measurement – a vaginal pH > 5.0 can accompany atrophic changes.
• Assessment for co‑existing infections (e.g., bacterial vaginosis, candidiasis) that may mimic dryness.

Lab Tests (when indicated)

• Serum estradiol – especially in perimenopausal women.
• Thyroid function tests – hypothyroidism can contribute to mucosal dryness.
• Autoimmune panel (ANA, anti‑SSA/SSB) if Sjögren’s syndrome is suspected.
• Vaginal swab for microscopy and cultures if infection is a concern.

In most cases, a thorough history and visual exam are sufficient to diagnose vaginal xerosis. When the cause is unclear, targeted laboratory work helps rule out systemic contributors.

Treatment Options

Management aims to restore moisture, improve the health of the vaginal epithelium, and alleviate discomfort. Treatment is individualized based on severity, underlying cause, and patient preferences.

Non‑prescription (OTC) Options

• Water‑based lubricants – ideal for sexual activity; reapply every 2–3 hours.
• Silicone‑based lubricants – longer lasting, safe with condoms.
• Vaginal moisturizers (e.g., hyaluronic acid‑based gels) – used 2–3 times weekly to maintain baseline hydration.
• Gentle, fragrance‑free cleansers – avoid soaps that can strip natural oils.

Prescription Hormonal Therapies

• Topical estrogen (cream, ring, tablet) – restores mucosal thickness within 2–4 weeks. Typical dose: estradiol 0.01–0.03 mg cream applied 2–3 times weekly.^[5]
• Vaginal estrogen ring** (e.g., Estring) – releases low‑dose estradiol continuously for up to 90 days.
• Systemic estrogen therapy – considered when vasomotor or bone health symptoms coexist; requires individualized risk/benefit assessment (see FDA guidance).
• Selective estrogen receptor modulators (SERMs) – ospemifene 60 mg daily is FDA‑approved for moderate to severe dyspareunia due to vulvovaginal atrophy.^[6]

Non‑estrogen Prescription Options

• Prasterone (DHEA) vaginal inserts – 6.5 mg delivering localized androgen conversion, improving lubrication without systemic androgen effects.^[7]
• Topical calcineurin inhibitors (e.g., tacrolimus) – used off‑label for lichen sclerosus‑related dryness.

Procedural Interventions

• Laser vaginal rejuvenation (CO₂ or Er:YAG) – stimulates collagen remodeling; evidence shows short‑term symptom relief, but long‑term safety data are limited.^[8]
• Radiofrequency (RF) therapy – similar mechanism to laser, with modest improvement in moisture scores.

Lifestyle & Self‑Care Measures

• Quit smoking & limit alcohol consumption.
• Stay well‑hydrated (≥ 8 cups water/day).
• Wear breathable, cotton underwear; avoid tight synthetic garments.
• Use a humidifier in dry climates or during winter heating season.
• Engage in regular pelvic floor exercises to improve local circulation.

Living with Xerosis of the Vaginal Mucosa

Daily management can dramatically improve quality of life. Below are practical tips:

• Consistent moisturization – apply a vaginal moisturizer (e.g., hyaluronic acid gel) at bedtime, even if you are not sexually active.
• Lubricant preparation – keep a small bottle of water‑based lubricant in your purse or bedside drawer for spontaneous intimacy.
• Gentle hygiene – wash the external genitalia with warm water only; pat dry.
• Avoid irritants – ditch scented tampons, douches, and bubble baths.
• Sexual communication – discuss discomfort with your partner; use ample lubricant and consider slower, foreplay‑focused activity.
• Follow‑up schedule – if using prescription estrogen, have a check‑up every 6–12 months to assess response and side‑effects.
• Track symptoms – a brief diary (date, severity, triggers) helps clinician adjust therapy.

Prevention

While some factors (age, genetics) are unavoidable, the following measures can lower the risk or delay onset of vaginal xerosis:

• Maintain a balanced diet rich in phytoestrogens (soy, flaxseed) – may modestly support estrogenic activity.
• Regular aerobic exercise improves systemic circulation, benefiting genital tissue.
• Limit use of systemic medications known to cause dryness; discuss alternatives with your provider.
• Stay up to date with menopause‑related health checks (bone density, cardiovascular risk), as comprehensive care often includes vaginal health.
• Consider low‑dose vaginal estrogen prophylactically if you’re entering menopause early and have risk factors (consult your clinician).

Complications

If left untreated, vaginal xerosis can lead to several complications:

• Vulvovaginal atrophy – progressive thinning of the epithelium, increasing fracture risk of the mucosa.
• Dyspareunia – chronic pain may affect intimate relationships and mental health.
• Urinary tract infections (UTIs) – reduced mucosal barrier can predispose to bacterial colonization.
• Pelvic floor dysfunction – chronic irritation may contribute to muscle spasm.
• Psychological impact – anxiety, reduced self‑esteem, or depression linked to sexual dysfunction.
• Secondary infections – fissures or microtears can become portals for bacterial or fungal infection.

When to Seek Emergency Care

---

References

1. American College of Obstetricians and Gynecologists. Menopausal Hormone Therapy. 2022.
2. National Institute on Aging. “Menopause.” Updated 2023.
3. Mayo Clinic. “Vaginal Dryness.” Accessed April 2024.
4. National Comprehensive Cancer Network. “Breast Cancer – Hormone Therapy.” 2023.
5. International Society for the Study of Women’s Sexual Health. “Topical Estrogen for Vaginal Atrophy.” 2022.
6. U.S. Food & Drug Administration. “Ospemifene (Osphena) Prescribing Information.” 2021.
7. NIH. “Prasterone Vaginal Insert (Intrarosa) Clinical Data.” 2023.
8. World Journal of Menopause. “Laser and Radiofrequency for Genitourinary Syndrome of Menopause: A Systematic Review.” 2023.